Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer

K ShigemitsuY NaomotoY ShirakawaM HaisaM GunduzN TanakaA case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapyJpn J Clin Oncol32310314200210.1093/jjco/hyf06712411570

SH BaxiB BurmeisterJA HarveyM SmithersJ ThomasSalvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: retrospective reviewJ Med Imaging Radiat Oncol52583587200810.1111/j.1440-1673.2008.02023.x

W HartwigO StrobelF LordickMW BuchlerJ WernerMultimodal therapy of esophageal cancerZ Gastroenterol46120712132008(In German)

W GuoYG JiangCurrent gene expression studies in esophageal carcinomaCurr Genomics10534539200910.2174/13892020978950388820514215

CC LinKP PapadopoulosNovel targeted therapies for advanced esophageal cancerDis Esophagus20365371200710.1111/j.1442-2050.2007.00730.x17760648

WP TewDP KelsenDH IlsonTargeted therapies for esophageal cancerOncologist10590601200510.1634/theoncologist.10-8-59016177283

DM NettelbeckV JeromeR MullerGene therapy: designer promoters for tumour targetingTrends Genet16174181200010.1016/S0168-9525(99)01950-210729833

D KoL HawkinsDC YuDevelopment of transcriptionally regulated oncolytic adenovirusesOncogene2477637774200510.1038/sj.onc.120904816299536

DL LichtensteinWS WoldExperimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmissionCancer Gene Ther11819829200410.1038/sj.cgt.7700765

H JiangC Gomez-ManzanoFF LangR AlemanyJ FueyoOncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomasCurr Gene Ther9422427200910.2174/15665230978975335619860656

RW WaltersP FreimuthTO MoningerI GanskeJ ZabnerMJ WelshAdenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escapeCell110789799200210.1016/S0092-8674(02)00912-112297051

HS PandhaLH StockwinJ EatonCoxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategiesProstate Cancer Prostatic Dis6611200310.1038/sj.pcan.4500611

Y AbdolazimiM MojarradM PedramMH ModarressiAnalysis of the expression of coxsackievirus and adenovirus receptor in five colon cancer cell linesWorld J Gastroenterol1363656369200710.3748/wjg.v13.i47.636518081225

M YamashitaA InoK KawabataF SakuraiH MizuguchiExpression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cellsInt J Cancer12116901696200710.1002/ijc.2285217546646

Y WangS ThorneJ HannockA novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenovirusesClin Cancer Res11351360200515671566

M AndersM ViethC RockenLoss of the coxsackie and adenovirus receptor contributes to gastric cancer progressionBr J Cancer100352359200910.1038/sj.bjc.660487619142187

JH LeePA MarksHistone deacetylase inhibitors in the therapy of cancer: much to learnEpigenomics2723725201010.2217/epi.10.5922122077

M KitazonoME GoldsmithT AikouS BatesT FojoEnhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228Cancer Res6163286330200111522619

B Segura-PachecoB AvalosE RangelD VelazquezG CabreraHDAC inhibitor valproic acid upregulates CAR in vitro and in vivoGenet Vaccines Ther510200710.1186/1479-0556-5-1017892546

R SomechS IzraeliA J SimonHistone deacetylase inhibitors - a new tool to treat cancerCancer Treat Rev30461472200410.1016/j.ctrv.2004.04.00615245778

JW RamosThe regulation of extracellular signal-regulated kinase (ERK) in mammalian cellsInt J Biochem Cell Biol4027072719200810.1016/j.biocel.2008.04.00918562239

CA BenedictPS NorrisTI PrigozyThree adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2J Biol Chem27632703278200110.1074/jbc.M00821820011050095

W LuS ZhengXF LiJJ HuangX ZhengZ LiIntra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trialWorld J Gastroenterol1036343638200415534920

K TothWS WoldIncreasing the efficacy of oncolytic adenovirus vectorsViruses218441866201010.3390/v209184421994711

Q HeY LiuQ ZouYS GuanTransarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinomaWorld J Gastroenterol1723532355201110.3748/wjg.v17.i18.235321633603

D MarchionP MunsterDevelopment of histone deacetylase inhibitors for cancer treatmentExpert Rev Anticancer Ther7583598200710.1586/14737140.7.4.58317428177

W WeichertHDAC expression and clinical prognosis in human malignanciesCancer Lett280168176200910.1016/j.canlet.2008.10.04719103471

G ChenBB WangFJ LiEnhancive effect of histone deacetylase inhibitor trichostatin a on transfection efficiency of adenovirus in ovarian carcinoma cell line A2780Ai Zheng24119612002005(In Chinese)

RC PongYJ LaiH ChenEpigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cellsCancer Res6386808686200314695181

JA McCubreyLS SteelmanWH ChappellRoles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochim Biophys Acta177312631284200710.1016/j.bbamcr.2006.10.00117126425

S BoldtUH WeidleW KolchThe kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathwaysExp Cell Res2838090200310.1016/S0014-4827(02)00018-612565821

M AndersC ChristianM McMahonF McCormickWM KornInhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cellsCancer Res6320882095200312727824

N BagheriM ShiinaDA LauffenburgerWM KornA dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibitionPLoS Comput Biol7e1001085201110.1371/journal.pcbi.100108521379332